Welcome to Newtec Pharmaceuticals
Sales Login CMS ERP Login Forum Wikipedia
Sales Login CMS ERP Login Forum Wikipedia
R&D Initiatives

Research & Development

Our Research & Development

Leading the Way in Pharmaceutical Innovation

At Newtec Pharmaceuticals, we are committed to advancing healthcare through innovative research and development. Our dedicated team of scientists and researchers work tirelessly to discover and develop new therapies that address unmet medical needs.

10+ Therapeutic Group
20+ Brands
Newtec Lab

State-of-the-Art Facilities

Advanced research labs equipped with cutting-edge technology

Our Core Research Areas

Neuroscience

Exploring novel treatments for neurodegenerative diseases and psychiatric disorders.

Rare Diseases

Exploring novel treatments for neurodegenerative diseases and psychiatric disorders.

Respiratory

Exploring novel treatments for neurodegenerative diseases and psychiatric disorders.

Immunology

Exploring novel treatments for neurodegenerative diseases and psychiatric disorders.

Cardiovascular

Exploring novel treatments for neurodegenerative diseases and psychiatric disorders.

Onchology

Labore consectetur qLabore consectetur qLabore consectetur qLabore consectetur q

Development Process

Our Drug Development Journey

From discovery to market, advancing healthcare through innovation

Phase 1

Discovery

  • Target identification
  • Lead compound discovery
  • Initial screening
2-4 Years
Phase 2

Preclinical

  • Laboratory testing
  • Animal studies
  • Safety assessment
1-2 Years
Phase 3

Clinical Trials

  • Phase I: Safety trials
  • Phase II: Efficacy studies
  • Phase III: Large-scale trials
6-7 Years
Phase 4

FDA Review

  • Application review
  • Safety monitoring
  • Approval decision
1-2 Years

Our Development Pipeline

Sorry! No data found
Drug Candidate Therapeutic Area Target Indication Development Phase